Silverarc Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26,374
| Closed | -$3.84M | – | 92 |
|
|
2022
Q2 | $3.84M | Sell |
26,374
-76,123
| -74% | -$11.1M | 1.18% | 20 |
|
|
2022
Q1 | $4.36K | Buy |
102,497
+22,149
| +28% | +$942 | 1.8% | 13 |
|
|
2021
Q4 | $11.1M | Buy |
80,348
+18,451
| +30% | +$2.54M | 4.49% | 2 |
|
|
2021
Q3 | $8.6M | Buy |
61,897
+5,271
| +9% | +$732K | 4.86% | 1 |
|
|
2021
Q2 | $5.5K | Buy |
56,626
+6,537
| +13% | +$635 | 2.45% | 8 |
|
|
2021
Q1 | $3.42M | Buy |
50,089
+33,589
| +204% | +$2.3M | 1.87% | 20 |
|
|
2020
Q4 | $1.41M | Buy |
+16,500
| New | +$1.41M | 0.82% | 41 |
|